TRIM29 acts as a potential senescence suppressor with epigenetic activation in nasopharyngeal carcinoma.

Yue, Caifeng; Qian, Yuanmin; Wang, Chang; Chen, Jiewei; Wang, Jing; Wang, Zifeng; Wan, Xiangbo; Cao, Sumei; Zhu, Jingde; Tao, Qian; Yan, Min; Liu, Quentin (2023). TRIM29 acts as a potential senescence suppressor with epigenetic activation in nasopharyngeal carcinoma. Cancer science, 114(8), pp. 3176-3189. Wiley 10.1111/cas.15852

Preview

Text Cancer_Science_-_2023_-_Yue_-_TRIM29_acts_as_a_potential_senescence_suppressor_with_epigenetic_activation_in_nasopharyngeal.pdf - Published Version Available under License Creative Commons: Attribution-Noncommercial-No Derivative Works (CC-BY-NC-ND). Download (9MB) | Preview

Epigenetic alterations marked by DNA methylation are frequent events during the early development of nasopharyngeal carcinoma (NPC). We identified that TRIM29 is hypomethylated and overexpressed in NPC cell lines and tissues. TRIM29 silencing not only limited the growth of NPC cells in vitro and in vivo, but also induced cellular senescence, along with reactive oxygen species (ROS) accumulation. Mechanistically, we found that TRIM29 interacted with voltage-dependent anion-selective channel 1 (VDAC1) to activate mitophagy clearing up damaged mitochondria, which are the major source of ROS. In patients with NPC, high levels of TRIM29 expression are associated with an advanced clinical stage. Moreover, we detected hypomethylation of TRIM29 in patient nasopharyngeal swab DNA. Our findings indicate that TRIM29 depends on VDAC1 to induce mitophagy and prevents cellular senescence by decreasing ROS. Detection of aberrantly methylated TRIM29 in the nasopharyngeal swab DNA could be a promising strategy for the early detection of NPC.

Interest & Impact

Downloads

47 since deposited on 31 May 2023
36 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item